Interactions between metabolism and circadian clocks: reciprocal disturbances
Department of Neurobiology of Rhythms, Institute of Cellular and Integrative Neurosciences, Centre National de la Recherche Scientifique, UPR3212 associated with University of Strasbourg, Strasbourg, France
Department of Neurobiology of Rhythms, Institute of Cellular and Integrative Neurosciences, Centre National de la Recherche Scientifique, UPR3212 associated with University of Strasbourg, Strasbourg, France
Etienne Challet, CNRS and University of Strasbourg, Institute of Cellular and Integrative Neurosciences, 5 rue Blaise Pascal, Strasbourg, FR 67000, France. firstname.lastname@example.org
Obesity is a medical condition of excess body fat, recognized as a global epidemic. Besides genetic factors, overconsumption of high-energy food and a sedentary lifestyle are major obesogenic causes. A newly identified determinant is altered circadian rhythmicity. To anticipate and adapt to daily changes in the environment, organisms have developed an endogenous circadian timing system, comprising a main circadian clock, located in the suprachiasmatic nucleus (SCN) of the hypothalamus, principally synchronized to the light–dark cycle. Secondary peripheral clocks are found in various tissues, such as the liver, pancreas, and adipose tissue. These clocks control the rhythmic patterns of myriad metabolic processes. We will review the evidence that metabolic dysfunction is associated with circadian disturbances at both central and peripheral levels and, conversely, that disruption of circadian clock functioning can lead to obesity. The roots of these reciprocal interactions will be illustrated by transcriptional crosstalk between metabolic and circadian systems. Chronotherapeutic approaches of dieting to maintain or restore a proper circadian alignment could be useful to limit the magnitude of metabolic risks.
Over recent decades, obesity has become a major health problem, while at the same time being one of the leading preventable causes of death in the world.1 Obesity is a pathological condition defined as excessive fat accumulation and is associated with major complications, such as diabetes, hypertension, and cardiovascular diseases. Besides a few genetic factors, the main contributor to obesity is an overconsumption of food that is high in calories and saturated fat. In addition to high-fat, hypercaloric diets, sedentary lifestyles have supplanted regular physical activity, resulting in a positive energy balance (more energy intake, less energy expenditure) and obesity.2
Along with these factors, timing aspects of food intake and metabolic regulation have to be taken into consideration. In living organisms, most essential biological functions show a rhythmic pattern close to 24 hours. These endogenous daily variations, called circadian rhythms (from the latin: circa meaning about and dies meaning day), allow organisms to anticipate and prepare for periodic changes in the environment (e.g., light–dark cycle or food availability). The timing and duration of many physiological, metabolic, and behavioral processes are therefore dictated by a circadian timing system in coordination with the environment.
After a brief introduction of the circadian timing system, we will review the literature showing that the occurrence of obesity and/or diabetes is associated with circadian disturbances. Next, we will present laboratory studies demonstrating that direct circadian disruptions can have a broad impact on metabolism. We will also highlight the fact that irregular mealtimes and/or unusual lighting conditions are major contributors of circadian misalignment, perturbing both clock rhythmicity and metabolic homeostasis. By a reinforcing effect, circadian misalignment, resulting from inappropriate timing of food intake and/or exposure to unusual sleep/wake cycles, increases the likelihood of metabolic risk factors, and can even lead to metabolic disruptions. Finally, we will illustrate the transcriptional interactions between metabolism and the circadian system, and their importance in the development of overweight.
The circadian metabolism
The circadian timing system: an overview
In mammals, the circadian timing system is composed of several endogenous clocks, allowing biological functions to oscillate and be in phase with daily changes in the environment. The main circadian clock is located in the SCN of the anterior hypothalamus. The SCN is composed of multiple coupled cellular clocks that can generate circadian oscillations.3 For a proper phase adjustment of the circadian timing system to the external environment, SCN neurons receive direct input from the retina in order to be synchronized (i.e., reset) to the 24-h light–dark cycle.4 When light activates photoreceptors, in particular the intrinsically photosensitive retinal ganglion cells, nerve impulses are conducted directly through the retinohypothalamic tract to the SCN.5 As a result, the synchronized SCN orchestrates the rhythmicity of many aspects of metabolism, physiology, and behavior via neuronal connections and humoral factors, with a 24-h period (Fig. 1).
The functioning of a circadian clock is dependent on a core clock mechanism involving specific genes called “clock genes.” Among them period homolog 1–3 (Per1, Per2, Per3), cryptochrome 1,2 (Cry1, Cry2), circadian locomotor output cycles kaput (Clock) or its analog neuronal PAS domain protein 2 (Npas2), brain and muscle Arnt-like 1 (Bmal1), reverse viral erythroblastis oncogene products (Rev-erba and Rev-erbb), and retinoic acid-related orphan receptors (Rora, Rorb, Rorg) are essential.6 Clock genes are coexpressed (in virtually all tissues) and their products reciprocally interact at the transcriptional/translational levels to generate circadian oscillations. At least three autoregulatory feedback loops are interconnected: one positive in which CLOCK and BMAL1 dimerize to activate the E-box-mediated transcription of Per and Cry genes; one negative whereby upon reaching a critical concentration, PER and CRY proteins enter into the nucleus to inhibit the transactivation mediated by CLOCK:BMAL1, therefore inhibiting their own transcription; and an interconnecting loop, in which Rors can activate the transcription of Bmal1 and Npas2, whereas Rev-erbs can repress Bmal1, Clock, and Npas2, via retinoic acid-related orphan receptor response element (RORE) (Fig. 2).7–10 This loop ensures the fine tuning of circadian rhythms. In addition, posttranslational mechanisms such as protein phosphorylation, affect stabilization, degradation, and subcellular localization of clock proteins, thus contributing to the molecular clockwork.11
Circadian control of metabolic functions
A few hypothalamic nuclei, including the paraventricular nucleus, receive direct neuronal connections from the SCN12,13 and project to peripheral tissues, such as the liver,14,15 pancreas,16 or adipose tissue17 via autonomic output pathways. Considerable experimental work has highlighted the important role of hypothalamic nuclei in the control of feeding and energy metabolism. The ventromedial hypothalamic nucleus, lateral hypothalamus, and arcuate nucleus (ARC) contain glucose-sensing neurons and receive nutritional information from blood-borne signals and neuronal messages from brainstem nuclei, including parabrachial nucleus and nucleus of the solitary tract (NTS). Among the key hormones that modulate feeding via hypothalamic activity, leptin synthesized by adipocytes acts on ARC, in particular, to inhibit appetite and stimulate energy expenditure.18 Insulin, released from the β cells of the pancreas, also has anorexigenic effects on the metabolic hypothalamus.19 On the other hand, ghrelin, released by the stomach, activates neuropeptide Y/Agouti-related peptide-containing neurons in the ARC to increase appetite and decrease energy expenditure.20 An important role of the SCN is to orchestrate the internal ticking of different central and peripheral tissues. Therefore, 24-h rhythmic patterns can be observed for a plethora of metabolic functions, such as glucose,21,22 nonesterified fatty acids (NEFA), insulin,22 and leptin levels.23
The clock genes mentioned above are not only expressed in the SCN, but also in other brain regions and peripheral tissues.24–26 In the liver, clock genes show a robust circadian pattern of expression.25 In rats, destruction of the SCN abolishes the circadian rhythm of food intake.27 SCN lesions do not abolish Per2 rhythms in peripheral tissues, but produce internal desynchrony.28 Microarray analysis of the mouse liver transcriptome showed that 9% of more than 2,000 genes studied oscillate in a circadian manner and may be under the control of the SCN.29 Thus, it is likely that the SCN modulates both behavior and metabolism by adjusting the phase of peripheral oscillators. Recent genome-wide transcriptome analyses performed in the SCN, liver, and adrenal glands of mice, revealed that around 10% of transcripts are regulated in a circadian manner.30–35 Of the 49 nuclear receptors that are key actors of metabolic regulations (see below), approximately 40% were cyclic in the liver or white adipose tissue (WAT).36 Liver posttranscriptional and translational mechanisms contribute as well to circadian coordination.37 While the master clock in the SCN is mainly synchronized by light, clock gene oscillations in peripheral tissues can be shifted by feeding time (Fig. 1).25,38,39 In contrast, the SCN clock is relatively impervious to the synchronizing effect of meal time, provided that the animals are exposed to a light–dark cycle and ingest enough daily energy. Under severe food restriction (i.e., caloric restriction), however, the phase of the SCN and its synchronization to light are modified.40 Expression in the SCN of receptors to metabolic hormones (i.e., insulin, ghrelin, and leptin) raises the possibility that peripheral hormonal signals can feed back to the SCN.41–43
Therefore, the whole circadian system participates in the daily variation of metabolism. Several biological approaches and genetic models have given further insight into the maintenance of metabolic homeostasis and the crosstalk between the circadian system and metabolism, as will be further discussed below.
Metabolic diseases are associated with circadian disturbances
Genetic obesity and diabetes
Monogenic causes of obesity and diabetes are relatively rare, especially in humans. For instance, early-onset obesity has been associated with a mutation in the leptin receptor in humans.44 In rodents, however, genetic syndromes of obesity and diabetes mellitus offer models of choice to analyze circadian disturbances associated with metabolic physiopathology.
In obese Zucker rats, which carry a mutation (i.e., fa) in the leptin receptor gene, daily rhythms of locomotor activity, body temperature, and feeding are phase advanced (i.e., the active phase starts in the afternoon in contrast to the nocturnal onset in littermates) and their day–night amplitude is generally reduced.45–47 Increased daytime feeding is also observed in obese mice carrying the null mutation of a receptor to prostaglandin E2 (i.e., EP3 subtype).48 As a rule, the amplitude of the sleep–wake cycle and activity–rest rhythm is dampened in genetically obese rats and mice, diabetic or not, due in part to increased wake/activity during daytime and increased sleep at night.49–54
The molecular clockwork in peripheral tissues is consistently disrupted in genetically obese, diabetic or not, mice. More precisely, in obese ob/ob and KK mice as well as in obese and diabetic KK-AY mice, the amplitude of daily profiles of clock gene expression in the liver or white adipose tissue is generally reduced, if not barely sizeable.55,56 In the liver of obese and diabetic db/db mice, the molecular clockwork is differentially modified according to the clock gene considered.51
Of interest, in ob/ob mice, alterations in peripheral clocks occur earlier than metabolic symptoms, such as morbid obesity and hyperinsulinemia, thus suggesting that altered clockwork can play a role in obesity in addition to the specific deficiency of leptin.55 Within the central nervous system of ob/ob or KK-AY mice, clock gene oscillations have been studied in the NTS. The most salient changes concern Bmal1 and Rev-erba, whose daily expression is up- and downregulated, respectively.57 Moreover, the molecular clockwork of the SCN is not markedly affected in leptin-deficient, obese (i.e., ob/ob) mice.55 Unexpectedly in view of the severe dampening of overt rhythmicity in db/db mice, the amplitude of SCN molecular oscillations is significantly increased in these mice compared to littermates.51 Finally, it is worth mentioning that ob/ob mice show increased photic resetting of the master clock.54
In nature, species are not often confronted with food abundance. On the contrary, food can be rare for most animals and foraging is a key for survival (thus contributing to energy expenditure). Consequently, obese animals in the wild are uncommon, except for some species in which overweighting is important to support long periods of fasting (e.g., penguins, bears), and those species living in proximity to humans and consuming greasy food that is discarded by people. Most laboratory-based research on obesity is carried out in rodents.58 Control animals usually have an ad libitum access to a normocaloric chow diet. Despite this free access, most rodents regulate their consumption and the time when they eat and do not become obese.
Obesity can be induced by feeding rodents on an ad libitum basis with a high-fat diet (HFD, more than 50% of metabolizable energy derived from fat). Both the amount and dietary fat type alter body mass and composition.59 Short-term high-fat feeding reduces circadian variations of leptin levels in rats60 and humans,61 thus suggesting that dampened circulating leptin could contribute to the development of obesity. In mice, high-fat feeding attenuates the daily pattern of food intake, with a higher consumption during the day and a concomitant decrease during the active period, before significant mass gain. In WAT of mice fed with HDF, expression of metabolic genes can be downregulated at night, such as sterol regulatory element-binding protein 1c (Srebp-1c) or fatty-acid binding protein 4 (Fabp4), while expression of others is barely affected, like acetyl-CoA carboxylase (Acc) and fatty acid synthase (Fas). Other transcriptional changes are detected in the liver of these mice: expression of Acc, Fas, and Fabp1 is upregulated, while the nighttime peak of Srebp-1c is phase-advanced to the afternoon. Moreover, changes in the concentration and temporal pattern of expression of glucose, insulin, leptin, and NEFA are also observed.62 High-fat feeding also leads to difficulties in maintaining wakefulness during the active period and increases nonrapid eye movement sleep in mice63 as well as postprandial sleepiness in humans,64 suggesting that the metabolic state affects neural structures regulating sleep. Equally interesting, HFD seems to have a direct effect on the main circadian clock. In mice, HFD lengthens the free-running period62 and disrupts photic synchronization of the SCN to light, as shown by slower re-entrainment to shifted light–dark cycle and reduction in light-induced phase shifts.65 There is also a clear change in neuropeptide expression in the mediobasal hypothalamus, despite no major modification of the core clock machinery in that region.62 In the brainstem, more precisely in the NTS, mice fed with HFD display altered daily patterns of clock gene expression, including downregulated Rev-erba, and upregulated Bmal1 and Clock mRNA levels.57 Taken together, these results suggest that central dysfunctions may contribute to the development of obesity.
Oscillations of clock genes have been found in human WAT,66 but no difference has been detected in the characteristics of these oscillations between lean, overweight, and diabetic individuals.67 By contrast, the circadian timing of peripheral tissues is markedly modified by fat overload in rodents. HFD alters the diurnal variation in glucose tolerance, and insulin sensitivity by influencing clock functioning.68 In the liver, changes are seen in the level as well as the rhythmic pattern of major components of lipid homeostasis and adiponectin metabolic pathway, with parallel modifications in clock gene expression.62,69 In HFD-fed animals, expression of metabolic actors is asynchronous in liver and adipose tissue, suggesting the importance of temporal coordination among metabolic tissues. Furthermore, HFD also attenuates the amplitude of Clock, Bmal1, and Per2 in adipose tissue.62 Hence, altered circadian clock function within adipose tissue may promote excess fat storage (especially intra-abdominal fat). However, it is important to note that HFD-induced changes in clock gene expression could be gender specific, since a recent study in female mice did not obtain the same results. Indeed, eight weeks of HFD had only mild effects on clock gene profiles in the liver and adipose tissue, in spite of the presence of hyperlipidemia, hyperglycemia, and overweight.70 Moreover, the time and duration of feeding are also important. Four or eight weeks of HFD failed to alter peripheral clocks, whereas 11 weeks did.70,71 The differences between strains, gender, starting age of HFD feeding, and its duration, add a level of complexity to the comprehension of the risk factors that trigger obesity in rodents.
In summary, impairment of clock gene oscillations and metabolic pathways may explain the altered coordination of metabolic functions and clock-controlled output signaling, contributing to obesity and associated disorders (e.g., diabetes, sleep disturbances). Recent evidence also demonstrates that disruption of the circadian timing system solely, has various consequences on metabolism.
Circadian disruption is associated with metabolic dysfunctions
Altered endogenous clockwork
As aforementioned, clock genes are expressed in virtually all tissues and circadian clocks participate in the daily regulation of metabolic functions such as glucose and lipid metabolism.22,68
One of the first clock genes studied was Clock. Homozygous C57BL/6J Clock mutant mice are hyperphagic, show a dampened feeding pattern, with increased food intake during the rest period, and attenuated energy expenditure at night, thus contributing to fat excess. Clock mutant mice display severe metabolic alterations, including hypercholesteronemia, hypertriglyceridemia, hepatic steatosis, and hyperglycemia. In addition, Clock mutation leads to day–night changes in the expression of hypothalamic neuropeptides, like CART (Cocaine and amphetamine regulated transcript) and orexin mRNA, which play a role in central circuits controlling feeding and arousal.72 Furthermore, Clock mutation induces profound changes in glucose homeostasis, such as increased insulin sensitivity and altered gluconeogenesis.68 Of interest, in the liver, Clock has been shown to directly drive the expression of glycogen synthase 2 gene via E-boxes.73 In Clock mutant mice generated on a CBA/6CaH background (which synthesize melatonin contrary to the C57BL/6J strain), impairments in glucose tolerance, insulin secretion, liver Pepck mRNA expression, and increased insulin sensitivity are also observed, although these mice do not become spontaneously obese unlike C57BL/6J Clock mutants.74 Moreover, Clock (Jcl:ICR) mutant mice display levels of triglycerides and NEFA lower than control mice, and cholesterol and glucose levels do not differ. Due to reduced lipid absorption and hepatic lipogenesis, these mice challenged with HFD show reduced body mass elevation, leptin, and insulin levels.75,76 In spite of these discrepancies, due notably to strain-related differences, mutation of the Clock gene clearly has an impact on lipid metabolism, since Clock has been shown to participate in liver cholesterol accumulation77 and to amplify obesity in ob/ob mice.78
Bmal1, a close partner of Clock, has been shown to participate in adipocyte differentiation and lipogenesis.79 Sensitivity to exogenous insulin is increased by deletion of Bmal1, while gluconeogenesis is suppressed.68 Liver-specific deletion of Bmal1 in mice nicely confirmed its strong involvement in glucose metabolism. L-Bmal1−/− mice have impaired expression of clock-related genes involved in hepatic glucose regulation such as genes encoding glucose transporter 2, glucokinase, or pyruvate kinase. L-Bmal1−/− mice were hypoglycemic during the resting period, were more glucose tolerant, had normal insulin sensitivity and production, and normal total body fat content compared to wild-type mice.80 Altogether, these results demonstrate that Clock and Bmal1 modulate hepatic function to regulate glucose and fatty acid homeostasis. Interestingly, two Bmal1 haplotypes have been associated with diabetes in humans81 as well as Clock polymorphisms and related haplotypes that may play a role in the development of obesity.82,83
Recent elegant studies have explored the role of Clock and Bmal1 in the pancreatic islets, demonstrating that the pancreas harbors a functional circadian oscillator.84,85 They showed that pancreas-specific Bmal1 mutant mice have higher blood glucose levels during the whole 24-h cycle, impaired glucose tolerance, and reduced insulin secretion. Moreover, pancreatic islets of these mutant mice have altered development and produced less insulin, suggesting that intact clock functioning in the pancreas is essential for normal insulin secretion.85 This study establishes clearly that circadian components can regulate local metabolism.
Mutation of the core clock gene Per2 can also lead to abnormal conditions. In Per2−/– (Per2tm1Brd) mice, daily corticosterone rhythm is markedly attenuated. Of interest, when fed with HFD, these mice eat more during the rest period compared to wild-type mice and develop obesity.86 Moreover, the rhythmic pattern in Per2−/– mice of alpha-melanocyte-stimulating hormone (α-MSH), a powerful appetite suppressing peptide, is disrupted and peripheral injection of α-MSH induces weight loss.86 Interestingly, the circadian rhythm of Per2 was dampened in the mediobasal hypothalamus of Clock mutant mice that are obese.72 In mice in which Per2 is fully ablated, lipid metabolism was altered with decreases in both plasma NEFA and total triacylglycerol (TAG), and TAG contents in the WAT.87 In Per2−/− mice, and to a lesser extent in Per1−/− mice, glucose tolerance was increased (i.e., improved) compared to wild-type animals.88 By contrast, in Per1−/− and Per2−/− double-mutant mice (129/sv background), glucose tolerance and insulin sensitivity were both attenuated.80 Triple-mutant mice for Per1-Per2-Per3 gain more body mass on HFD than wild-type mice, similar to Per3 single-mutant mice, thus indicating that the Per3 mutation alone accounts for the obese phenotype.89
Along with core clock components, secondary actors of circadian oscillations take part in metabolic functions. Rora, activator of Bmal1 transcription, has been shown to participate in the regulation of apolipoprotein C-III (Apo C-III) gene involved in triglyceride metabolism,90 and lipid homeostasis in skeletal muscle.91Rev-erba, repressor of Bmal1, is involved in adipocyte differentiation92,93 and rhythmic bile and lipid homeostasis.94Rev-erba−/− mice displayed elevated serum Apo C-III and triglycerides levels.95 Moreover, although the deletion of Rev-erba alone has only a minor effect on hepatic glucose regulation,94 the alterations are more pronounced with concomitant mutation of Per2.96 Indeed, the expression of key enzymes of glucose metabolism, such as glucose-6-phosphatase or glucokinase, was more affected in the liver of Rev-erba−/−/Per2 mutant mice.
From all these results, it is tempting to think that studying the effects of clock gene disruption could shed light on the incapacity of physiological control mechanisms to cope with adverse consequences, for instance of overweight. However, the effects of a mutation in the Nocturnin gene, which encodes a circadian deadenylase important for posttranscriptional regulation of circadian-related genes,97 do not fit with this thought. Nocturnin knockout mice exhibit no change in circadian rhythm of locomotor activity and liver clock gene expression, although they have altered expression of metabolic genes, reduced lipid absorption, and are resistant to diet-induced obesity. This study indicates that circadian metabolism can be disrupted without noteworthy modification in core clock functioning while a specific subset of circadian downstream targets involved in lipid metabolism is affected.98 Ongoing research into the complex crosstalk between components of the circadian system and metabolism may lead to prevention and improve treatment of metabolic disorders in the future.
Altered rhythmic “environment”
There are two main external causes of disruption in circadian rhythmicity. The first one concerns chronic changes in timing of light–dark cycles, such as chronic jet lag. The second way relates to behavioral activity (e.g., physical activity, feeding) occurring during the usual resting period (nighttime in humans, daytime in nocturnal rodents) with long-term shifts, such as during night work (also called permanent shift work), or short-term shifts, like rotating shift work. As detailed below, these desynchronizing situations have deleterious consequences on circadian organization and metabolic health.
Housing mice in light–dark cycles that are too short (i.e., 20 h) for enabling daily synchronization of their master clock leads to larger body mass gain and increased insulin/glucose ratio, indicative in the fasted state of insulin resistance.99 The same paradigm has also been shown to aggravate cardiovascular disease in mice.100 In human subjects exposed to controlled 28-h sleep–wake cycles under dim light (so-called “forced desynchronization” protocol), circadian misalignment impairs glucose tolerance and reduces sensitivity to insulin.101 Additionally, constant exposure of mice to bright or dim light leads to increased body mass and reduced glucose tolerance compared to mice housed under a regular light–dark cycle.102
Repeated weekly shifts of 24-h light–dark cycle in rats fed with regular chow diet lead to chronic desynchronization and trigger higher body mass gain103 as well as impaired insulin regulation.104 Interestingly, expression of FABP4 is upregulated in WAT of rats exposed to repeated light–dark shifts.105 A number of epidemiological studies in different countries have highlighted increased metabolic risks for cardio-metabolic syndrome, including increased disturbances in lipid metabolism (e.g., high levels of cholesterol and triglycerides),106–110 glucose metabolism (e.g., high fasting insulin and glucose),108,111 increased concentration of leucocytes, reflecting systemic inflammation,108 and hypertension.106,110
Chronic sleep disturbance or sleep restriction under a regular light–dark cycle alters glucose homeostasis in rats.112 In humans, recurrent sleep debt is a newly identified risk factor for obesity and diabetes,113,114 indicating that it is likely an aggravating factor for metabolic disturbances in night workers.
Being nocturnal animals, laboratory rats and mice exposed to a light–dark cycle consume most of their daily food during the night period. In rodents, daytime feeding is a potent synchronizer of peripheral clocks.25,38,39,115 Access to food restricted to a few hours during the light phase usually leads to mild body mass loss or no change at all.38,116,117 In more rare cases, food-restricted rats with chow diet available only for a few hours can increase their body mass.118 A clear contribution of circadian timing of food intake in body mass gain has been shown in Zucker rats (Fig. 3).46 As mentioned above, fa/fa rats ingest a larger proportion of food during the usual resting phase (i.e., light phase) than control animals. This study was the first to demonstrate that by limiting food access to the normal period of activity and feeding (i.e., nighttime in nocturnal rats), Zucker rats gained less body mass compared to free-fed animals, in spite of similar amounts of food intake between both groups.46 More recent observations confirm nicely the metabolic consequences of unusual timing of feeding. Mice fed ad libitum with HFD display a rapid increase in daytime feeding that takes place weeks before the obese phenotype is detectable.62 Furthermore, when HFD was restricted to the light phase, mice gained more body mass than those on the same diet but with access limited to the dark phase (Fig. 3).119
Another paradigm used to awaken rodents during their resting period (i.e., daytime) is forced activity that leads to internal desynchronization.120 Keeping food intake to the normal feeding period (i.e., night) in spite of diurnal forced activity prevents body mass and metabolic changes.121 Considering that exposure to bright light at night is an aggravating factor for the occurrence of pathologies in human night workers,122 it may be clinically relevant to develop shift-work models in day-active animals.
In humans, night-eating syndrome (NES) is characterized by a delayed pattern of calorie intake (i.e., lack of appetite in the morning and evening or nocturnal hyperphagia). In contrast to this delayed meal timing, the daily rhythm of plasma ghrelin is largely phase advanced, while the rhythm in plasma glucose is phase opposed in patients with NES compared to those in control subjects.123 Elevated nocturnal, but not “evening,” feeding has been correlated with an increased risk of overweight in some,124,125 but not all epidemiological studies.126
Transcriptional networks connecting molecular clockwork and metabolic pathways
As aforementioned, a set of clock genes is responsible for the generation of circadian oscillations. From genetic strategies allowing modifications of the genome in mice, it has been discussed above that most, if not all, clock gene deletions lead to a broad range of metabolic diseases. In addition, we have introduced the effects of unhealthy food and incorrect timing of food intake on metabolic regulatory centers and the core clock machinery. In this last section, we will give an overview of the emergent understanding of the communication within the circadian clock circuitry. We will illustrate the different molecular pathways by which clock-related nuclear receptors are involved in metabolism and the effects of nutrient “sensors” on core clock components (Fig. 4).
The nuclear receptors’ dynamic network
Transcriptomal analyses have demonstrated that a large number of nuclear receptors are expressed in a circadian manner.36 Among them, Rors, Rev-erbs, and peroxisome proliferator-activated receptor (Ppars) genes appear to be pivotal players at the interface between the circadian system and metabolism.127
As introduced above, RORs and REV-ERBs compete for binding RORE in clock gene promoters.7–10 Interestingly, Rev-erba can repress its own transcription on a functional REV-ERBα binding site (RevDR2) located in its promoter.128 RORα being able to bind to this site participates in the control of Rev-erba transcription.129 Hence, genes containing either RORE or RevDR2 in their promoter are activated by RORα and repressed by REV-ERBα. This highlights the occurrence of dynamic interactions within the core clock machinery. In skeletal muscle, Rora directly regulates the mouse caveolin-3 (Cav-3) and carnitine palmitoyltransferase-1 (Cpt1) genes, involved in fatty acid metabolism.91Rora also enhances activity of the human Apo C-III gene promoter90 and binds to the rodent apolipoprotein A-I (ApoA1) RORE.130 Additional evidence for a role of Rora in metabolism is provided by the fact that cholesterol is a putative ligand of RORα.131
Numerous studies have shown that REV-ERBs also influence lipid and energy homeostasis. The expression of a dominant negative version of Rev-erbb in transfected cell lines attenuates expression of genes involved in lipid metabolism, such as Fabp3-4, cluster of differentiation 36 (Cd36), stearoyl-coenzyme A desaturase 1 (Scd1), and cellular energy balance (e.g., uncoupling protein 3, Ucp3). Similarly to Rora, Rev-erba can bind directly to the human Apo C-III promoter95 and the rat Apoa-I promoter RORE.132 For the repressive action on Bmal1 transcription, Rev-erba has been shown to recruit the nuclear receptor corepressor (NCoR)/histone deacetylase 3 (HDAC3) complex.133 Of interest, genetic disruption of NCoR1-HDAC3 interaction in mice induces changes in Bmal1 expression and circadian behavior with concomitant effects on metabolism (e.g., increased insulin sensitivity, altered expression of metabolic genes). Surprisingly, loss of a functional NCoR1-HDAC3 complex also protects mice from diet-induced obesity.134 On the other hand, a recent study has explored the role of the circadian genomic recruitment of HDAC3 in the mouse liver. They showed that REV-ERBα controls the circadian expression of lipid metabolism genes by recruiting the repressive chromatin modifier HDAC3 (and NCoR) to the genome during the light period, therefore preventing lipogenesis at a time when animals are resting. In addition, deletion of either Hdac3 or Rev-erba results in hepatic steatosis indicating steady lipogenesis.135 These findings demonstrate that the circadian control of epigenetic modifiers by clock components is critical for normal metabolic processing. Additional evidence of the involvement of Rev-erbs in metabolism is provided by studies on heme, which has diverse biological functions, including oxygen sensing, cell respiration, and metabolism.136 Heme, whose expression occurs in a circadian manner,137 can bind to both REV-ERBs.138 Heme binding to REV-ERBs facilitates recruitment of the nuclear corepressor NCoR.133,138 The rate-limiting enzyme in heme biosynthesis, aminolevulinate synthase 1 (Alas1), is directly controlled by the clock.139 Heme biosynthesis is also influenced by the nutritional status through the regulation of Alas1 by the PPARγ coactivator 1α (PGC-1α).140 This nuclear receptor coactivator is induced by fasting140 and participates in a variety of metabolic pathways such as glucose and lipid regulation.141 Moreover, both PGC-1α and heme are able to modulate the expression of circadian genes.137,142,143 These results illustrate how REV-ERBs can sense dynamic metabolic changes and transmit them to the core clock machinery.
PPARs are members of the nuclear hormone receptor superfamily of ligand-activated transcription factors. The three PPARs (α, δ, γ) have been shown to regulate carbohydrate, lipid, lipoprotein, and energy metabolism.144,145Ppara is rhythmically expressed in tissues with high fatty acid catabolism rates such as the liver and adipose tissue. Pparg is rhythmically expressed in liver and WAT, while Ppard expression oscillates in liver and brown adipose tissue (BAT).36 PPARα is likely to play a role in connecting circadian physiology to metabolism. Pparα-deficient mice (Ppara−/−) have normal rhythmic behavior and clock gene expression in the SCN, but PPARα deficiency alters Bmal1 and Per3 expression in the liver. Moreover, Ppara deficiency leads to disrupted phase resetting of Bmal1 when food is provided during the light period, indicating that PPARα may control Bmal1. Indeed, PPARα directly regulates hepatic Bmal1 expression through a response element located in its promoter.146 Besides, it has been shown that Ppara is a clock-controlled gene147 and daytime feeding inverts its circadian expression pattern in the liver.146 Interestingly, PPARα is also connected to the nuclear receptor Rev-erba because the PPARα agonists (fibrates) induce liver expression of Rev-erba. In addition, PPARα (as well as PPARγ) can directly transactivate Rev-erba via RevDR2 located in its promoter.92,132,148 Clearly, all these data demonstrate that the metabolic sensor PPARα may play a prominent role in circadian functioning. Other results indicate that PER2 has the capacity to recruit PPARα or REV-ERBα for the modulation of Bmal1 expression,96 again showing intimate interactions between clock and metabolic components in the clock circuitry.
PPARγ and PPARδ are both involved in energy homeostasis. A recent study reveals that PER2 can interact directly with PPARγ to repress its transcriptional activity. Ablation of Per2 in cell culture increased induction of adipogenic genes, while deletion of Per2 in mice results in slight changes in circadian expression of PPARγ target genes in WAT.87 These results demonstrate that the control of PPARγ by a circadian actor is essential for normal lipid metabolism. Interestingly, PGC-1 (PPARγ coactivator 1, as introduced above), which is involved in thermogenesis and associated metabolic responses,142,149 is rhythmically expressed in phase with Pparg, Ppard, and thermogenic genes, such as Ucp1 and thyroid receptor α (Tra), in BAT.36 Furthermore, PGC-1 can specifically bind PPARγ,149 whereas the latter can also interact with the Ucp1 promoter.150 All these data suggest that PPARs could transmit (diurnal) changes in heat dissipation to the circadian system.
These data suggest that nuclear receptors are controlling an amazing array of metabolic functions and are capable of communicating the body's metabolic state to the core clock machinery. Incidentally, other nuclear receptor subgroups also participate in the interplay between metabolic and circadian physiology (e.g., retinoid X receptor, liver X receptor, and estrogen-related receptor).36,127,151
Nutrient sensors interact with clock components
The tight connection between the circadian timing system and metabolism is also underscored by the role of nutrient sensors. Clock adaptation to metabolic reactions is likely to be achieved also by direct input of nutrient sensing regulators to the intrinsic clock machinery. However, we are aware that the subdivision between nuclear receptors presented above and metabolic sensors that we will introduce in this section may appear rather arbitrary.
Recent evidence has demonstrated that local changes in cellular energy, such as redox reactions (portmanteau for reduction-oxidation), can influence the circadian expression of core clock genes and clock-related nuclear receptors. Nicotinamide adenine dinucleotide (NAD+) and its reduced form NADH are coenzymes found in all living cells. NAD+ also exists in a phosphorylated form NADP+ and can be reduced to NADPH. NAD(P)+ and NAD(P)H are involved in cellular redox reactions. Interestingly, CLOCK:BMAL1 and NPAS2:BMAL1 heterodimers can sense intracellular redox status. The DNA-binding activities of these dimers are influenced by both reduced and oxidized forms of NAD(H) and NADP(H) in an opposing manner. The reduced forms (NADH and NADPH) activate DNA binding of CLOCK:BMAL1 and NPAS2:BMAL1, whereas the oxidized forms (NAD+ and NADP+) inhibit it, consistent with a role as redox sensors.152 These results raise the possibility that cell energy metabolism can influence circadian rhythmicity. For example, these clock protein sensors might participate in the rhythm imposed by the alternation of fasting and feeding. Indeed, NAD:NADH ratio is modified under fasting and feeding conditions since starvation lowers NADP:NADPH (i.e., shift toward a reduced state) in both rat liver mitochondria and cytoplasm.153 Thus, for feeding synchronization, it is plausible that the cellular redox status could transmit changes in energy metabolism directly to the clock architecture. In this context, it is tempting to think that irregular mealtimes could also contribute to circadian misalignment by subtle perturbations of local circadian oscillator functioning.
Sirtuin 1 (SIRT1), another energy sensor, has recently been found to link circadian to metabolic physiology. SIRT1 is a NAD-dependent histone deacetylase that contributes to epigenetic gene silencing and a plethora of biological processes ranging from gluconeogenesis, insulin secretion and sensitivity, lipid regulation, mitochondrial activity, thermogenesis, adipogenesis and adipocyte differentiation, and apoptosis. SIRT1 also plays a crucial role in the caloric restriction-dependent life span extension.154–156 SIRT1, whose expression occurs in a circadian manner, has been shown to influence circadian transcription of several clock genes (e.g., Per2, Cry1, Bmal1, and Rora).157 Moreover, SIRT1, can directly bind CLOCK:BMAL1 heterodimers and promote deacetylation of PER2,157 BMAL1, and histone H3.158 Interestingly, SIRT1 can also affect expression of metabolic regulatory transcription factors. It can interact with and deacetylate PGC-1α to control the expression of gluconeogenic and glycolytic genes.159 In addition, hepatic SIRT1 is able to modulate the expression of PPARα.160 Importantly, SIRT1 can also repress the fat regulator PPARγ and it is activated during fasting to promote fat mobilization in WAT, again demonstrating its clear implication in lipid homeostasis.161 Furthermore, SIRT1 has been shown to be decreased in adipose tissue endothelial cells from obese human subjects.162 Of interest, since fat accumulation is associated with several adverse complications, such as diabetes and hypertension, caloric restriction (and consequent fat depletion) that has multiple biological and life-extending benefits163 may be used to prevent or treat metabolic disruptions.
In addition to NAD(P)+ and SIRT1, AMP-activated protein kinase (AMPK) is a further important nutrient sensor. AMPK is sensitive to fluctuations in the cellular AMP:ATP ratio and can be activated by various factors such as exercise, glucose deprivation, or leptin treatment. The functions of AMPK cover the whole-body energy balance (e.g., food intake, body mass, lipid and glucose homeostasis, cholesterol and triglyceride synthesis, energy expenditure).164 In mouse skeletal muscle and cultured myotubes, AMPK has been demonstrated to regulate genes involved in energy metabolism by acting in coordination with SIRT1. Interestingly, AMPK activation increases NAD+ levels, which in turn enhance SIRT1 activity, resulting in the deacetylation and activation of the downstream SIRT1 target PGC-1α.165 Deletion of the AMPKγ3 subunit in mice leads to impaired expression profiles of clock genes in skeletal muscle in response to the AMPK activator AICAR (5-amino-4-imidazole-carboxamide riboside), and attenuated daily variations of the respiratory exchange ratio.166 AMPK also has direct actions on the clock machinery. AMPK phosphorylates and destabilizes CRY1.167 Casein kinase Iɛ, an important regulator of PER proteins stability, is also phosphorylated by AMPK that induces subsequent degradation of PER2 and phase shifts of peripheral oscillators.168 Recently, it has been demonstrated that mice deficient for either AMPKα1 or AMPKα2 have altered circadian feeding behavior and free-running periods.169 Surprisingly, the rhythmic gene expression of leptin, PGC-1α and nicotinamide phosphoryl-transferase (NAMPT), a rate-limiting enzyme in the NAD+ salvage pathway regulated by CLOCK:BMAL1,170,171 was abolished in AMPK-deficient mice.169 This study reveals that AMPK is to some extent involved in the cycling of the NAMPT-(NAD+)-SIRT1-PGC-1α pathway. In addition, prolonged activation of SIRT1 by its agonist SRT1720 causes an indirect activation of AMPK, and both SIRT1 and AMPK respond to low-energy levels.164,172 Therefore, SIRT1 and AMPK may have overlapping functions to ensure the fine tuning of metabolic and clock regulations. Consequently, if a drug exerts effects on these actors, it is advisable to also explore its influence on the core clock machinery.
Finally, it is important to mention that the mammalian molecular circadian clockwork (based on transcriptional–translational events) overviewed in this section is not a unique cellular clock model. Indeed, circadian redox rhythms of peroxiredoxins, which are antioxidant enzymes, can occur independently of transcription, thus defining a metabolic nontranscriptional oscillator.173
At the molecular/cellular levels, the recent findings cited above highlight multiple transcriptional crossroads between circadian and metabolic pathways in organs involved in metabolism, namely liver, adipose tissue, pancreas, and muscle. Nuclear receptors such as Rors and Rev-erbs are well situated to receive metabolic signals and integrate them into the core clock architecture. In addition, we show that fluctuations in cellular metabolism can directly influence the transcriptional activity of core clock components such as Cry1, Per2, Clock, and Bmal1.
At the level of the organism, the circadian timing system provides internal temporal organization controlled locally by peripheral clocks/oscillators reset by feeding time, and supervised by the master SCN clock mainly reset by ambient light. Impairment of this internal timing due to altered endogenous clockwork or misalignment with external cues, light, and/or mealtime, has a deleterious impact on metabolic health.
Overconsumption of “junk” (most often hypercaloric) food is a well-acknowledged causal factor of obesity. In addition to the type and quantity of food eaten, we have reviewed here the importance of the hour of the day when food is eaten. In short, it seems that the recommendation of “doing the right thing at the right time” is relevant for the relation between food intake and circadian rhythmicity, in that significant amounts of ingested fuels at the wrong circadian time (i.e., resting period) can predispose to increased adiposity and other metabolic risks. This link, together with the putative obesogenic property of repeated light–dark shifts or chronic shift work, leads to the concept that we called “chronobesity”.65 Furthermore, metabolic diseases are associated with circadian disturbances in behavior and physiology, not only in peripheral organs but also in the brain. Together, these findings suggest that management of circadian disorders is especially important in obese and diabetic people to prevent a kind of vicious circle that could amplify health problems.
We propose that dietary strategies for limiting, or preventing, overweight and obesity could be further optimized by taking into account circadian rhythmicity to maintain (or restore) normal temporal organization and synchronization to local time, that is, by developing chronotherapeutic approaches of dieting.
Due to space limitations, we apologize for not citing additional pertinent references. We are grateful to Dr. David Hicks for helpful comments on the manuscript. J.D. is supported by a doctoral fellowship from the French Ministry of National Education and Research, and E.C. is supported by Centre National de Recherche Scientifique, Université de Strasbourg and Agence Nationale pour la Recherche “Jeunes chercheurs/jeunes chercheuses” ANR-07-JCJC-0111.